Clinical Trial Update: Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study [NA]

View source ↗

Summary

The ANDROMEDA-SHOCK study evaluating early goal-directed therapy guided by peripheral perfusion in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Septic Shock, Hyperlactatemia | NA | Status: COMPLETED